OpenAlex
PricingAboutJobs
Log inGet started
Work

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972

HTML PDF

Year: 2003
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
DOI: 10.1093/annonc/mdg157
Authors: M.J. van den Bent, O. Chinot, W. Boogerd, J. Bravo Marques, M.J.B. Taphoorn, J.M. Kros, C.C.D. van der Rijt, C.J. Vecht, N. De Beule, B. Baron
Institutions: Erasmus MC, Hôpital de la Timone, The Netherlands Cancer Institute, Instituto Português de Oncologia Francisco Gentil, University Medical Center Utrecht, Medisch Centrum Haaglanden, Stichting Haaglanden Medisch Centrum, European Organisation for Research and Treatment of Cancer, European Organisation for Research and Treatment of Cancer
Language: English

Topic: Glioma Diagnosis and Treatment
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: temozolomide, mixed oligoastrocytoma, procarbazine, lomustine, and vincristine, second-line chemotherapy, alkylating agents, treatment response, progression-free survival, hematologic toxicity
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W2123453386
FWCI: 8.833
Cites: 19
Cited by: 169
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms